Dr. Ariel Katz
President & Chief Executive Officer
Dr. Ariel Katz joined Enzymotec in August 2000 as President and Chief Executive Officer. He has also headed our VAYA Pharma segment since January 2012. Prior to joining Enzymotec, Dr. Katz held various positions with the Dead Sea Bromine Group of Israel Chemicals Ltd. for 14 years, including senior positions in research and development, plant management, marketing and business development. Dr. Katz holds a bachelor's degree in chemistry and an M.Sc. in economic management both from Ben-Gurion University of the Negev, Beer Sheva, Israel, and a PhD in engineering in the field of artificial intelligence from Exeter University, UK. From 2003 until 2010 Dr. Katz was a guest lecturer in the Biotechnology Department in the Technion - Israel Institute of Technology, Haifa, Israel.
VP & Chief Financial Officer
Oren Bryan joined Enzymotec in June 2008 as our Vice President and Chief Financial Officer. Prior to joining Enzymotec, he served as Chief Financial Officer of MIND C.T.I. Ltd., a global provider of real-time, product-based mediation, billing and customer care solutions for voice, data, video and content service from 2006 to 2008 and Controller of MIND C.T.I. Ltd. from 2005 to 2006. Prior thereto, Mr. Bryan served as a Controller of Dor Chemicals Ltd. from 2001 to 2005 and of a private software company from 2000 to 2001 and was an accountant with Ernst & Young (Israel) from 1997 to 2000. Mr. Bryan is a certified public accountant and holds a bachelor's degree (summa cum laude) in economics and accounting from Haifa University, Israel.
VP Process Development
Gai Ben-Dror has served as our Vice President Process Development, and previously as our Director of Process Development since joining Enzymotec. Mr. Ben-Dror, a chemical engineer with 16 years of experience in process development, joined Enzymotec in 2001.
He was responsible for the development and commercialization of all our products and for the building of our technological and analytical teams. Prior to joining us, he was a plant and pilot engineer in the Dead Sea Bromine Group of Israel Chemicals Ltd. from 1996 to 2000, a research team leader in a hardware development company (Sense-IT Ltd.) and a project manager in water treatment engineering company (Chimtec Ltd). He holds a bachelor's degree in chemical engineering and an MBA from Ben-Gurion University of the Negev, Beer Sheva, Israel.
Yariv Gratz served as Enzymotec Vice President – Operations since June 2014. Prior to joining Enzymotec, Mr. Gratz served as Director of Operations at Nilit where he was responsible for managing manufacturing facilities in Israel and China including global engineering and projects department and the industrial engineering unit, overseeing a total of 650 employees. Prior to this position, he served as Vice President – Operations for MIS – Israel. From 2010 to 1992, he held positions at Sanmina SCI, EIL – Electrochemical Industries and Gadot Bio Chem. Mr. Gratz received his M.B.A. from Herriot Watt and B.Sc in Chemical Engineering from The Technion – Israel Institute of Technology.
VP Business Development
Ariel Blumovich joined Enzymotec in July 2014 as our Vice President – Business Development. Prior to joining Enzymotec, Mr. Blumovich served as Global Business Development Manager at Samsung, in which role he executed high growth deals in the pharmaceutical and hi-technology business segments, including multinational joint-ventures, licensing, sales agreement, and strategic alliances. Prior to joining Samsung, Mr. Blumovich held positions at Sanofi-Aventis, Teva Pharmaceutical Industries, Ltd., and Israeli Electric Corp. He received his M.B.A. from The Tuck School of Business at Dartmouth College and his B.Sc, Mechanical Engineering from The Technion – Israel Institute of Technology.
VP Human Resources
Itay Dromi joined Enzymotec in July 2014 as our Vice President – Human Resources with over 20 years of global experience in human resources and organizational management. Prior to joining Enzymotec, Mr. Dromi served in multiple senior human resource positions at Teva Pharmaceutical, Ltd, including as Vice President – Human Resources TGO Asia Region and as Vice President – Human Resources of the Chemical Division. Mr. Dromi previously held human resource positions at Ultrashape and Delta Galil Industries. Mr. Dromi received his M.B.A from Bar Ilan University and an M.A. in Public Administration from the University of Haifa.
Vice President Nutrition Division
Shachar Carmi has served as our Vice President Sales, Nutrition Division since July 2014 and became our Vice President Nutrition Division in February 2015. Prior to joining Enzymotec, from 2009 to June 2014, he served as Vice President Sales and Marketing at Biobee Sde Eliyahu, a leading producer of bumble bees for natural pollination and beneficial insects used in agriculture as an alternative to chemical pesticides. From 2007 to 2009, he served as Product Manager at Hazera Genetics, a leading breeder and supplier of vegetable seeds. Prior to that, he held positions at Milestone Agriculture, Inc. and Click Software. Mr. Carmi received his B.Sc. in Industrial Engineering from Tel Aviv Universityp>
President and CEO of Vaya Pharma USA
Rob Crim joined Enzymotec in August 2014 as President and CEO of Vaya Pharma USA. Mr. Crim has over 15 years experience in the global clinical nutrition and medical foods area. Most recently, Mr. Crim was an independent consultant focusing on the medical nutrition and healthcare clients. From 2004 to 2010, he held positions of increasing responsibility at Danone/Numico, including General Manager of the SHS business and Regional Vice President – North America and Global Business Development as well as serving on the Executive Committee of the Medical Nutrition Division. Prior to that, Mr. Crim held positions at Abbott, including Vice President – Consumer Nutritionals where he was responsible for the Ensure and Glucerna businesses. Mr. Crim has also held positions at Johnson & Johnson and Procter and Gamble. He received his M.B.A from University of Michigan and his B.A. from Harvard University.